OSTEOPOROSIS: DIAGNOSIS AND EFFECTIVE TREATMENT


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The comparative analysis showed that Osteomed forte proved to be more effective than calcium carbonate made by a foreign manufacturer and strontium ranelate in treating postmenopausal osteoporosis. An X-ray absorption technique was used to determine bone mineral density and the size of cavitary masses in the patients; the treatment cycle lasted 10 months.

Full Text

Restricted Access

About the authors

V. Strukov

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

L. Burmistrova

Research Institute Of Beekeeping

Rybnoe

D. Elistratov

OOO Parafarm

Penza

A. Kislov

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

O. Strukova-Jouns

Mansfield Medical Center

R. Galeeva

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

L. Kurashvili

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

V. Zhivotoschuk

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

L. Radchenko

Penza Institute for Postgraduate Training of Physicians, Ministry of Health of the Russian Federation

I. Boykov

Penza State University

Yu. Semirich

Penza State University

References

  1. Струков В.И., Джоунс О.В., Крутяков Е.Н. и др. Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей. Патент РФ на изобретение №2497533. Приоритет изобретения от 19.04.2012.
  2. Струков В.И., Джоунс О.В., Крутяков Е.Н. и др. Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей. Патент РФ на изобретение № 2498811. Приоритет изобретения от 19.04.2012.
  3. Струков В.И., Катюшина Ю.Г., Филиппова О.В. Остеомед - эффективный регулятор минеральной плотности костей и закрытия полостных образований при лечении пресенильного и сенильного остеопороза // Поликлиника. - 2013; 1 (1): 90-1.
  4. Bruyere O. et al. Strontion Ranelateon spinal osteoarthritis progression // Ann. Rheumatol. Disorder. - 2008; 67: 335-9.
  5. Kalinchenko S., Vishnevskiy E., Koval A. et al. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study // Aging Male. - 2008; 11 (2): 57-61.
  6. Mudali S., Dobs A., Ding J. et al. Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study // J. Clin. Endocrinol. Metab. - 2005; 90: 1202-9.
  7. Nathorst-Boos J., Floter A., Jarcander-Rollf M. Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido-effects on sexuality and psychological well-being // Maturitas. - 2006; 53: 11-8.
  8. Riverra-Woll L., Papalia M., Davis S. et al. Androgen insufficiency in women: diagnostic and therapeutic implications // Human Reprod. Update. - 2004; 10 (5): 421-32.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House